Diabetic neuropathy. Diabetes mellitus due to underlying condition with diabetic polyneuropathy
Conditions
Interventions
Intervention 1: Intervention group: After obtaining the necessary permits, the study begins. Intervention will be done for patients whose score is 7 or higher. Matching will be done according to the d
Sponsors
Yasouj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients with type 2 diabetes who have symptoms related to neuropathy. Age between 40 and 70 years old Be able to collaborate and communicate. No chronic diseases (vitamin B12 deficiency, vitamin D deficiency, folic acid deficiency, and kidney failure) Other causes that cause diabetic neuropathy will be excluded from the study, and patients who meet the inclusion criteria will be examined.
Exclusion criteria
Exclusion criteria: Having a severe physical, neurological, or psychiatric illness Taking drugs that are somehow effective in aggravating or alleviating neuropathy, such as: tricyclic antidepressants - antipsychotics - anticonvulsants (except pregabalin) and painkillers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diabetic neuropathy. Timepoint: Before and after the intervention. Method of measurement: Michigan Neuropathy Screening Instrument (MNSI). | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before and After the Intervention. Method of measurement: Visual Analogue Scale (VAS).;Tingling. Timepoint: Before and After the Intervention. Method of measurement: Frequency and Patient Description. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactEshaq Moradi Sheibani
Yasouj University of Medical Sciences
Outcome results
None listed